Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Univentricular Heart · Congenital Heart Disease · Heart Failure NYHA Class III · Heart Failure NYHA Class IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Karen Miller) · HLHS@mayo.edu
Contact: Study coordinator (Lori Riess) · HLHS@mayo.edu
Contact: Principal Investigator (Rebecca K Ameduri, M.D.)

Study leads

Timothy J Nelson, M.D., Ph.D.
Study Director
HeartWorks, Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Registry to Assess the Safety and Feasibility of the Subpulmonary Support with the Novel Venous Cannula in Patients with Failing/Absence of the Right Heart

Heart Failure · Univentricular Heart · Ventricular Dysfunction

Abroad (travel likely)Recruiting

Munich, Germany

Cardiac Magnetic Resonance Stress-perfusion Study in Patinets with Fontan Circulation

Univentricular Heart · Microvascular Dysfunction · Heart Failure

Abroad (travel likely)Recruiting

Stockholm, Sweden

Fontan Outcomes in Oligemia vs Plethora in Univentricular CHD

Congenital Heart Disease (CHD) · Univentricular Heart

Abroad (travel likely)Recruiting

Jakarta, Indonesia

PRecision Integrated Saturation Monitor

CHD - Congenital Heart Disease · Single Ventricle Heart Disease

Abroad (travel likely)Recruiting

Memphis, United States